Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Angelika Stehle"'
Autor:
Lisa Falchetto, Bernd Bender, Ian Erhard, Kim N. Zeiner, Jan A. Stratmann, Florestan J. Koll, Sebastian Wagner, Marcel Reiser, Khayal Gasimli, Angelika Stehle, Martin Voss, Olivier Ballo, Jörg Janne Vehreschild, Daniel Maier
Publikováno v:
BMC Research Notes, Vol 17, Iss 1, Pp 1-6 (2024)
Abstract Objective The concept of lines of therapy (LOT) in cancer treatment is often considered for decision making in tumor boards and clinical management, but lacks a common definition across medical specialties. The complexity and heterogeneity o
Externí odkaz:
https://doaj.org/article/2ddb10a220324f82a22c2648f4c609fc
Autor:
Maximilian N. Kinzler, Katrin Bankov, Julia Bein, Claudia Döring, Falko Schulze, Henning Reis, Scherwin Mahmoudi, Vitali Koch, Leon D. Grünewald, Angelika Stehle, Dirk Walter, Fabian Finkelmeier, Stefan Zeuzem, Peter J. Wild, Thomas J. Vogl, Simon Bernatz
Publikováno v:
Current Oncology, Vol 30, Iss 3, Pp 3516-3528 (2023)
Distinct immune patterns of hepatocellular carcinoma (HCC) may have prognostic implications in the response to transarterial chemoembolization (TACE). Thus, we aimed to exploratively analyze tumor tissue of HCC patients who do or do not respond to TA
Externí odkaz:
https://doaj.org/article/87d021d14c2c44dda2af6250382a0a39
Autor:
Simon Bernatz, Oleg Elenberger, Jörg Ackermann, Lukas Lenga, Simon S. Martin, Jan-Erik Scholtz, Vitali Koch, Leon D. Grünewald, Yannis Herrmann, Maximilian N. Kinzler, Angelika Stehle, Ina Koch, Stefan Zeuzem, Katrin Bankov, Claudia Doering, Henning Reis, Nadine Flinner, Falko Schulze, Peter J. Wild, Renate Hammerstingl, Katrin Eichler, Tatjana Gruber-Rouh, Thomas J. Vogl, Daniel Pinto dos Santos, Scherwin Mahmoudi
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-9 (2023)
Abstract We aimed to identify hepatocellular carcinoma (HCC) patients who will respond to repetitive transarterial chemoembolization (TACE) to improve the treatment algorithm. Retrospectively, 61 patients (mean age, 65.3 years ± 10.0 [SD]; 49 men) w
Externí odkaz:
https://doaj.org/article/93254461f6d9412381cfcac4e1c1af0e
Autor:
Maximilian N. Kinzler, Angelika Stehle, Falko Schulze, Michael Hogardt, Thomas A. Wichelhaus, Volkhard A. J. Kempf, Fabian Finkelmeier, Jörg Trojan, Stefan Zeuzem, Andreas A. Schnitzbauer, Wolf O. Bechstein, Peter J. Wild, Dirk Walter
Publikováno v:
Liver International. 43:490-499
Colonization with multidrug-resistant organisms (MDRO) has been shown to impair survival in patients with various malignancies. Despite the increasing spread of MDRO, its impact on patients with cholangiocarcinoma (CCA) is unclear. Aim of this study
Autor:
Maximilian N. Kinzler, Falko Schulze, Katrin Bankov, Steffen Gretser, Nina Becker, Regina Leichner, Angelika Stehle, Nada Abedin, Jörg Trojan, Stefan Zeuzem, Andreas A. Schnitzbauer, Peter J. Wild, Dirk Walter
Publikováno v:
Pathology - Research and Practice. 238:154126
In recent years, histopathological characterization of intrahepatic cholangiocarcinoma revealed small duct type (SD-iCCA) and large duct type (LD-iCCA). Data on the prevalence of the subtypes are limited and highly varying. The aim of this study was
Publikováno v:
Cancer Letters. 365:37-46
Eribulin, a novel microtubule-interfering drug, was recently shown to exhibit high antitumor activity in vivo against various pediatric cancers. Here, we identify a novel synthetic lethal interaction of Eribulin together with Polo-like kinase 1 (PLK1